No Data
No Data
Haemonetics Positioned for Strong Growth: Buy Rating Justified Amidst Operational and Financial Optimism
Express News | Haemonetics Corp : Raymond James Raises Target Price to $120 From $100
Haemonetics Price Target Raised to $125.00/Share From $115.00 by JMP Securities
Haemonetics Price Target Raised to $125.00/Share From $115.00 by JMP Securities
4 Analysts Assess Haemonetics: What You Need To Know
During the last three months, 4 analysts shared their evaluations of Haemonetics (NYSE:HAE), revealing diverse outlooks from bullish to bearish.The table below provides a concise overview of recent ra
Haemonetics (HAE) Q4 Earnings Top Estimates, Margins Expand
Haemonetics Is Maintained at Outperform by Barrington Research
Haemonetics Is Maintained at Outperform by Barrington Research